FAP and ductal breast carcinoma in situ: In our study, using Calponin and FAP-α adjunctively improved the sensitivity of pathological diagnosis of DCIS by 13.6%, whereas the adjunctive use of Calponin and FAP-α improved the sensitivity of pathological diagnosis of DCIS-MI by 11.29%.